CS logo
small CS logo
Alpine Clinical Research Center

Boulder, Colorado, United States
Research institute in Boulder, Colorado
3434 47th St STE 201, Boulder, CO 80301

About Alpine Clinical Research Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
9
Eli Lilly and Company
6
Allergan
4
BioCryst Pharmaceuticals
3
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
3
Jazz Pharmaceuticals
3
Avadel
2
Bristol-Myers Squibb
2
Cephalon
2
Dermira, Inc.
2
Harmony Biosciences, LLC
2
Total Rows: 26

Clinical Trials at Alpine Clinical Research Center


During the past decade, Alpine Clinical Research Center conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 25 clinical trials were completed, i.e. on average, 104.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years55444411115511332233112266445522Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Experimental Medication For the Treatment of Generalized Anxiety Disorder
2004-11-01
2005-12-01
Completed
511
Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
2005-03-01
2006-05-01
Completed
540
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
2005-06-01
2006-07-01
Completed
175
Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx
2005-01-01
2013-03-01
Completed
1,008
Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD
2003-09-01
2006-09-01
Completed
ESCAPE Migraine Trial
2005-11-01
2012-03-01
Terminated
168
Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
2006-05-01
2006-11-01
Completed
420
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
2006-07-01
2008-06-01
Completed
349

Rows per page:

1–54 of 54

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Alpine Clinical Research Center" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Allergan" with 4 trials sponsored, "BioCryst Pharmaceuticals" with 3 trials sponsored and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alpine Clinical Research Center" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 9Pfizer: 9Eli Lilly and Company: 6Eli Lilly and Company: 6Allergan: 4Allergan: 4BioCryst Pharmaceuticals: 3BioCryst Pharmaceuticals: 3JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3Jazz Pharmaceuticals: 3Jazz Pharmaceuticals: 3Avadel: 2Avadel: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Cephalon: 2Cephalon: 2Dermira, Inc.: 2Dermira, Inc.: 2

Created with Highcharts 11.1.0Top CollaboratorsPfizer: 3Pfizer: 3CoLucid Pharmaceuticals: 2CoLucid Pharmaceuticals: 2Eli Lilly and Company: 1Eli Lilly and Company: 1Iqvia Pty Ltd: 1Iqvia Pty Ltd: 1National Institute ofNeurological Disordersand Stroke (NINDS): 1National Institute ofNeurological Disordersand Stroke (NINDS): 1Noven Pharmaceuticals, Inc.: 1Noven Pharmaceuticals, Inc.: 1Shire: 1Shire: 1Synteract, Inc.: 1Synteract, Inc.: 1

Clinical Trials Conditions at Alpine Clinical Research Center


According to Clinical.Site data, the most researched conditions in "Alpine Clinical Research Center" are "Alzheimer's Disease" (7 trials), "Alzheimer Disease" (4 trials), "Idiopathic Hypersomnia" (4 trials), "Attention Deficit Hyperactivity Disorder" (3 trials) and "Low Back Pain" (3 trials). Many other conditions were trialed in "Alpine Clinical Research Center" in a lesser frequency.

Clinical Trials Intervention Types at Alpine Clinical Research Center


Most popular intervention types in "Alpine Clinical Research Center" are "Drug" (49 trials), "Biological" (6 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "FT218" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Alpine Clinical Research Center


The vast majority of trials in "Alpine Clinical Research Center" are 54 trials for "All" genders.

Clinical Trials Status at Alpine Clinical Research Center


Currently, there are NaN active trials in "Alpine Clinical Research Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Alpine Clinical Research Center, undefined suspended trials, and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Alpine Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 40Phase 3: 40Phase 2: 12Phase 2: 12Phase 1: 2Phase 1: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 38Completed: 38Terminated: 11Terminated: 11Active, not recruiting: 2Active, not recruiting: 2Recruiting: 2Recruiting: 2Enrolling by invitation: 1Enrolling by invitation: 1